Pulmonx Corporation
NASDAQ:LUNG
5.77 (USD) • At close February 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Assets: | ||||||
| Current Assets: | ||||||
| Cash & Cash Equivalents
| 83.547 | 101.736 | 148.48 | 231.561 | 14.767 | 4.124 |
| Short Term Investments
| 33.555 | 39.402 | 31.561 | 0 | 13.58 | 0 |
| Cash and Short Term Investments
| 117.102 | 141.138 | 180.041 | 231.561 | 28.347 | 4.124 |
| Net Receivables
| 13.02 | 8.677 | 6.562 | 4.228 | 5.998 | 3.421 |
| Inventory
| 16.743 | 14.564 | 16.285 | 10.741 | 5.612 | 3.32 |
| Other Current Assets
| 3.557 | 3.972 | 4.752 | 3.12 | 1.114 | 0.443 |
| Total Current Assets
| 150.422 | 168.953 | 208.002 | 249.989 | 41.071 | 11.308 |
| Non-Current Assets: | ||||||
| Property, Plant & Equipment, Net
| 7.434 | 10.5 | 12.889 | 10.45 | 7.463 | 0.375 |
| Goodwill
| 2.333 | 2.333 | 2.333 | 2.333 | 2.333 | 2.333 |
| Intangible Assets
| 0.031 | 0.154 | 0.277 | 0.4 | 0.524 | 0.647 |
| Goodwill and Intangible Assets
| 2.364 | 2.487 | 2.61 | 2.733 | 2.857 | 2.98 |
| Long Term Investments
| 14.39 | 5.924 | 10.941 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0.408 | 0.479 | 0 | 0 | 0 |
| Other Non-Current Assets
| 3.171 | 5.404 | 0.252 | 0.536 | 2.142 | 0.35 |
| Total Non-Current Assets
| 27.359 | 24.723 | 27.171 | 13.719 | 12.462 | 3.705 |
| Total Assets
| 177.781 | 193.676 | 235.173 | 263.708 | 53.533 | 15.013 |
| Liabilities & Equity: | ||||||
| Current Liabilities: | ||||||
| Account Payables
| 1.497 | 1.758 | 1.582 | 1.472 | 2.681 | 1.289 |
| Short Term Debt
| 5.229 | 6.548 | 2.292 | 4.476 | 0.446 | 0 |
| Tax Payables
| 0.093 | 0.019 | 0.147 | 0.094 | 0.995 | 0.73 |
| Deferred Revenue
| 0.104 | 0.12 | 0.163 | 0.071 | 0.173 | 0.139 |
| Other Current Liabilities
| 16.234 | 10.047 | 13.366 | 6.413 | 9.866 | 5.914 |
| Total Current Liabilities
| 23.157 | 18.492 | 17.55 | 12.526 | 14.161 | 8.072 |
| Non-Current Liabilities: | ||||||
| Long Term Debt
| 36.195 | 24.932 | 24.168 | 24.986 | 226.707 | 33.605 |
| Deferred Revenue Non-Current
| 0 | 17.234 | 0 | -17.368 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0.114 | 0.094 | 0.037 | 0.062 | 0.043 | 0.048 |
| Other Non-Current Liabilities
| 0 | -3.849 | 0.179 | 0 | 0 | 140.614 |
| Total Non-Current Liabilities
| 36.309 | 21.177 | 24.384 | 25.048 | 226.75 | 174.267 |
| Total Liabilities
| 59.466 | 39.669 | 41.934 | 37.574 | 240.911 | 182.339 |
| Equity: | ||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 205.339 | 140.535 |
| Common Stock
| 0.039 | 0.038 | 0.037 | 0.036 | 0.019 | 0.017 |
| Retained Earnings
| -411.161 | -350.318 | -291.395 | -242.734 | -210.503 | -189.8 |
| Accumulated Other Comprehensive Income/Loss
| 2.64 | 1.575 | 1.712 | 1.685 | 1.373 | 1.333 |
| Other Total Stockholders Equity
| 526.797 | 502.712 | 482.885 | 467.147 | 21.75 | 21.124 |
| Total Shareholders Equity
| 118.315 | 154.007 | 193.239 | 226.134 | -187.378 | -167.326 |
| Total Equity
| 118.315 | 154.007 | 193.239 | 226.134 | -187.378 | -167.326 |
| Total Liabilities & Shareholders Equity
| 177.781 | 193.676 | 235.173 | 263.708 | 53.533 | 15.013 |